FDA approves a generic version of the drug Martin Shkreli monopolized

FDA approves a generic version of the drug Martin Shkreli monopolized

By DAMIAN GARDE

DREW ANGERER/GETTY IMAGES

The approval means Shkreli's company, once called Turing and now known as Phoenixus, will no longer have a monopoly on Daraprim.

READ MORE